Chembio Diagnostics Inc. buy melinda
Start price
05.07.17
/
50%
€5.55
Target price
13.11.17
€6.13
Performance (%)
7.32%
End price
13.11.17
€5.95
Summary
This prediction ended on 13.11.17 with a price of €5.95. The BUY prediction by melinda finished with a performance of 7.32%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Chembio Diagnostics Inc. | - | - | - | - |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by melinda for this prediction
In the thread Chembio Diagn.new diskutieren
Chembio
5. Juli (Reuters) - Chembio Diagnostics Inc: das System der Chembio DPP® zika, einschließlich der Mikrolauf DPP® von der Aufsichtsbehörde für Gesundheit von Brasilien zugelassen. Diagnosetests - Empfangene Zulassung für die kommerzielle Nutzung in Brasilien des Microdrive DPP durch ANVISA in Zusammenarbeit mit Bio-Manguinhos / Fiocruz.
Stopped prediction by melinda for Chembio Diagnostics Inc.
Chembio Diagnostics Inc.
Start price
Target price
Perf. (%)
€3.32
09.09.20
09.09.20
€5.00
04.11.21
04.11.21
-44.28%
05.11.21
05.11.21
Chembio Diagnostics Inc.
Start price
Target price
Perf. (%)
€4.20
23.07.20
23.07.20
€8.00
09.09.20
09.09.20
-20.95%
09.09.20
09.09.20
Chembio Diagnostics Inc.
Start price
Target price
Perf. (%)
€6.36
02.12.18
02.12.18
€6.77
22.01.19
22.01.19
-0.43%
22.01.19
22.01.19
Chembio Diagnostics Inc.
Start price
Target price
Perf. (%)
€6.36
28.02.18
28.02.18
€7.04
09.03.18
09.03.18
10.83%
09.03.18
09.03.18
Chembio Diagnostics Inc.
Start price
Target price
Perf. (%)
€6.15
05.07.17
05.07.17
€6.80
13.11.17
13.11.17
7.32%
13.11.17
13.11.17